W
William L. Roberts
Researcher at University of Utah
Publications - 142
Citations - 8203
William L. Roberts is an academic researcher from University of Utah. The author has contributed to research in topics: ADVIA Centaur & Kidney disease. The author has an hindex of 45, co-authored 142 publications receiving 7639 citations. Previous affiliations of William L. Roberts include ARUP Laboratories & Uppsala University.
Papers
More filters
Journal ArticleDOI
Evaluation of Nine Automated High-Sensitivity C-Reactive Protein Methods: Implications for Clinical and Epidemiological Applications. Part 2
William L. Roberts,Linda Moulton,Terence C. Law,Genesis Farrow,Margaret Cooper-Anderson,John Savory,Nader Rifai +6 more
TL;DR: Additional standardization efforts are required to ensure that hs-CRP results can be related to large-scale epidemiologic studies.
Journal ArticleDOI
FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
Jessica Kendrick,Alfred K. Cheung,James S. Kaufman,Tom Greene,William L. Roberts,Gerard Smits,Michel Chonchol +6 more
TL;DR: In advanced CKD, FGF-23 strongly and independently associates with all-cause mortality, cardiovascular events, and initiation of chronic dialysis.
Journal ArticleDOI
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona,Alan W. Partin,Martin G. Sanda,John T. Wei,George G. Klee,Chris H. Bangma,Kevin M. Slawin,Leonard S. Marks,Stacy Loeb,Dennis L. Broyles,Sanghyuk S. Shin,Amabelle B. Cruz,Daniel W. Chan,Lori J. Sokoll,William L. Roberts,Ron H.N. van Schaik,Isaac A. Mizrahi +16 more
TL;DR: The prostate health index may be useful in prostate cancer screening to decrease unnecessary biopsy in men 50 years old or older with prostate specific antigen 2 to 10 ng/ml and negative digital rectal examination with minimal loss in sensitivity.
Journal ArticleDOI
Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer.
Jorja D Warren,Wei Xiong,Ashley M. Bunker,Cecily P. Vaughn,Larissa V. Furtado,William L. Roberts,John C. Fang,Wade S. Samowitz,Karen A. Heichman,Karen A. Heichman +9 more
TL;DR: A sensitive blood-based CRC screening test using the SEPT9 biomarker specifically detects a majority of CRCs of all stages and colorectal locations.
Journal ArticleDOI
Evaluation of a (1→3)-β-d-Glucan Assay for Diagnosis of Invasive Fungal Infections
Jerry W. Pickering,Howard W. Sant,Catherine A. P. Bowles,Catherine A. P. Bowles,William L. Roberts,William L. Roberts,Gail L. Woods,Gail L. Woods +7 more
TL;DR: The results suggest that the Fungitel assay may be most useful for excluding invasive fungal infection.